导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.64% | 925/1050 |
| 近一周 | -0.36% | 53/1104 |
| 近一月 | -2.53% | 279/1102 |
| 近一季 | -14.21% | 820/1092 |
| 近半年 | -16.99% | 934/1070 |
| 近一年 | -21.83% | 929/1018 |
| 近两年 | 11.84% | 833/926 |
| 近三年 | -20.58% | 775/834 |
| 成立以来 | -0.77% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.95% 907/1070 |
24.05% 348/1101 |
- - |
- - |
| 2025 | 16.61% 727/1065 |
5.86% 349/1014 |
2.94% 439/1038 |
18.36% 653/1050 |
-9.59% 873/1065 |
| 2024 | -12.59% 812/1011 |
-13.39% 873/960 |
2.39% 178/983 |
1.97% 937/991 |
-3.33% 556/1011 |
| 2023 | -20.14% 673/952 |
8.54% 160/880 |
-13.83% 850/895 |
-5.12% 318/915 |
-10.00% 859/952 |
| 2022 | -29.33% 608/867 |
-17.74% 411/773 |
6.63% 428/806 |
-13.05% 466/845 |
-7.34% 717/867 |
| 2021 | - 349/740 |
0.80% 119/580 |
22.58% 125/659 |
-13.34% 580/704 |
-6.61% 621/740 |
| 2020 | 69.63% 146/554 |
- 157/419 |
38.45% 36/466 |
7.62% 309/517 |
13.85% 229/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发优势增长股票 VS. 东吴新产业精选股票A(580008) |